Partner Lisa Noller was quoted in an Agenda article, “SEC’s Broken Windows Sweep a ‘Game-Changer’ for Directors,” on October 13, 2014. The article discusses the Securities and Exchange Commission’s recent investigation of nearly three dozen individuals and companies after their respective boards and directors failed to follow disclosure procedures on insider transactions. Noller was quoted saying, “If they [company boards] detect outliers in their own trading patterns or their employees’ then they need to act on it and investigate. If you ignore the data and let the SEC find it first, you’re not only failing to discharge your duties as officers and directors, you’re also opening yourself up to an investigation.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”